German technology company ZEISS Group has reported a strong fiscal year 2024/25, with revenue totaling almost 12 billion euros and earnings before interest and taxes (EBIT) at 1.552 billion euros. However, the company’s four segments presented a mixed picture, highlighting the challenges faced in the current economic climate.
Despite these challenges, ZEISS Group remains resilient and continues to invest in innovative strength. “Targeted resilience measures and investments in our research and development have been key to our success in the past fiscal year,” said Andreas Pecher, President and CEO of ZEISS Group.
The company’s revenue increased by 9% to 11.896 billion euros, with an EBIT margin of 13%. However, the mixed picture in the four segments reflects the impact of increasing geopolitical tensions and trade barriers on the company’s operations.
“ZEISS is still operating in a dynamic and challenging business environment,” said Pecher. “The past fiscal year saw increased uncertainty in the markets, requiring us to adapt our strategic activities and strengthen our resilience measures.”
The company’s segment development also reflected the impact of these challenges, with the Semiconductor Manufacturing Technology segment experiencing a 23% increase in revenue, while the Industrial Quality & Research segment saw a 1% decrease. The Medical Technology segment, which is not identical to the Carl Zeiss Meditec Group, reported a 4% increase in revenue, and the Consumer Markets segment saw a 2% increase.
The full press release and further information can be found at www.zeiss.com/newsroom.
For press inquiries, please contact ZEISS Group’s Head of Corporate Brand, Communications and Public Affairs, Jörg Nitschke, at +49 7364 20-3242 or joerg.nitschke@zeiss.com.